TrialJournal for immunotherapy of cancer2020

Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study.

Kaichao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.